An Ebola vaccine: first results and promising opportunities.

@article{2015AnEV,
  title={An Ebola vaccine: first results and promising opportunities.},
  author={},
  journal={Lancet},
  year={2015},
  volume={386 9996},
  pages={830}
}
Today, The Lancet publishes the first results from a phase 3 cluster randomised trial of a novel Ebola virus vaccine. The study, sponsored and led by WHO, is a remarkable scientific and logistical achievement. In the midst of an extreme public health emergency, researchers, health workers, and community facilitators in Guinea included 7651 people in a trial to test the efficacy of a recombinant, replication-competent vesicular stomatitis virus-based vaccine expressing a surface glycoprotein of… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…